Jump to content

Indenolol

From Wikipedia, the free encyclopedia
Indenolol
Names
IUPAC name
1-(1H-Inden-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
DrugBank
EC Number
  • 262-323-5
KEGG
UNII
  • InChI=1S/C15H21NO2/c1-11(2)16-9-13(17)10-18-15-8-4-6-12-5-3-7-14(12)15/h3-4,6-8,11,13,16-17H,5,9-10H2,1-2H3
    Key: MPGBPFMOOXKQRX-UHFFFAOYSA-N
  • InChI=1/C15H21NO2/c1-11(2)16-9-13(17)10-18-15-8-4-6-12-5-3-7-14(12)15/h3-4,6-8,11,13,16-17H,5,9-10H2,1-2H3
    Key: MPGBPFMOOXKQRX-UHFFFAOYAY
  • CC(C)NCC(COC1=CC=CC2=C1C=CC2)O
Properties
C15H21NO2
Molar mass 247.338 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Indenolol is a beta-adrenergic blocker[1] for the treatment of hypertension (high blood pressure). It was investigated in the 1980s,[2] but is not known to be marketed as of 2021.[3] It is a derivative of a phenolic 4-indenol.

References

[edit]
  1. ^ Ali, I; Gaitonde, VD; Aboul-Enein, HY; Hussain, A (2009). "Chiral separation of beta-adrenergic blockers on CelluCoat column by HPLC". Talanta. 78 (2): 458–63. doi:10.1016/j.talanta.2008.11.043. PMID 19203609.
  2. ^ Trimarco, Bruno; Cuocolo, Alberto; Groothold, Gisela; Ricciardelli, Bruno; De Luca, Nicola; Volpe, Massimo; Veniero, Anna Maria; Condorelli, Mario (1985). "Indenolol: A New Antihypertensive Agent: Efficacy, Toxicity, and Hemodynamic Effects in a Crossover Double-Blind Study with Metoprolol". The Journal of Clinical Pharmacology. 25 (5): 328–336. doi:10.1002/j.1552-4604.1985.tb02850.x. PMID 4031109. S2CID 22844379.
  3. ^ DrugBank DB08952 . Accessed 2021-03-18.


pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy